GENE ONLINE|News &
Opinion
Blog

Prostate Cancer
Editors' Picks weekly highlights
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
Trials & Approvals Prostate Cancer
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
Deals BankruptcyClovis Oncology
Deep Into Bankruptcy Proceedings, Clovis Sells Cancer Med Rubraca
2023-04-10
Trials & Approvals Xtandi
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Trials & Approvals Keytruda
Merck’s Keytruda Falls Short In Two Trials
2023-03-01
Trials & Approvals Prostate Specific Membrane Antigen
Novartis’ Pluvicto Continues Winning Streak In Prostate Cancer Indication
2022-12-07
Trials & Approvals Janssen Pharmaceutica
Janssen Drops Out of Prostate Cancer Clinical Trial Due to Lack of Patients
2022-11-01
Partnerships Oncology
Genentech Bets $650 Million Biobucks on China’s Jemincare’s Prostate Cancer Prospect
2022-08-19
Trials & Approvals Prostate Cancer
Starpharma Announces Encouraging Interim Results for Prostate Cancer Drug
2021-11-27
Trials & Approvals PARP Inhibitor
AZ, Merck’s PARP Inhibitor Shines in Phase 3 Prostate Cancer Trial
2021-09-26
Special
Day 3 ESMO 2021 Roundup: Mirati’s KRAS Drug Surpasses Amgen’s in Colorectal Cancer Trial
2021-09-20
Trials & Approvals Prostate Cancer
Poseida Presents Encouraging Preliminary Data for Autologous CAR-T Candidate Against Solid Tumors
2021-08-31
ASCO
#ASCO21: Large Cohort Study by Foundation Medicine and Collaborators Reveal Disparities in Precision Cancer Care
2021-06-09
Trials & Approvals
Clovis Oncology’s PARP Inhibitor Shines in Preliminary Prostate Cancer Trial
2021-04-12
Trials & Approvals Targeted Radioligand Therapy
Novartis’ Acquired Asset from Endocyte Shines in Phase 3 Prostate Cancer Trial
2021-03-24
1 2
LATEST
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
Singapore’s NUS Medicine Launches Centre for Sustainable Medicine
2023-11-20
Pioneering Partnership: Africa CDC and China CDC Elevate Public Health Initiatives
2023-11-20
READ MORE
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top